Oxford BioTherapeutics is a clinical-stage oncology company based in Oxford, UK, Morristown, and San Jose, USA. The company develops immuno-oncology (IO) and antibody-drug conjugate (ADC) based therapies.
7
Funding Rounds
$25.9m
Money raised
Name | Phone | Social networks | |
---|---|---|---|
Ch** Ro**** |
|
- |